Publications
Publications
- April 1992 (Revised June 1993)
- HBS Case Collection
Biotechnology Strategies in 1992
Abstract
Describes the strategies of biotechnology companies which face similar uncertainties and illustrates different types of strategic responses to uncertainty. Each firm faces the strategic issues of which end-use industries to choose, how broad their product line should be, how to choose alliances, partnerships, and licenses to have sufficient funds without foregoing their profit potential, and how far to vertically integrate.
Keywords
Citation
Teisberg, Elizabeth O. "Biotechnology Strategies in 1992." Harvard Business School Case 792-082, April 1992. (Revised June 1993.)